- Home
- INGN vs TVGN Comparison
INGN vs TVGN Comparison
Compare INGN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGN
- TVGN
- Stock Information
- Founded
- INGN 2001
- TVGN 2020
- Country
- INGN United States
- TVGN United States
- Employees
- INGN N/A
- TVGN N/A
- Industry
- INGN Industrial Specialties
- TVGN Blank Checks
- Sector
- INGN Health Care
- TVGN Finance
- Exchange
- INGN Nasdaq
- TVGN Nasdaq
- Market Cap
- INGN 219.3M
- TVGN 179.0M
- IPO Year
- INGN 2014
- TVGN N/A
- Fundamental
- Price
- INGN $8.24
- TVGN $0.63
- Analyst Decision
- INGN Strong Buy
- TVGN Strong Buy
- Analyst Count
- INGN 3
- TVGN 1
- Target Price
- INGN $11.00
- TVGN $10.00
- AVG Volume (30 Days)
- INGN 148.1K
- TVGN 449.7K
- Earning Date
- INGN 11-05-2025
- TVGN 11-18-2025
- Dividend Yield
- INGN N/A
- TVGN N/A
- EPS Growth
- INGN N/A
- TVGN N/A
- EPS
- INGN N/A
- TVGN N/A
- Revenue
- INGN $343,472,000.00
- TVGN N/A
- Revenue This Year
- INGN $8.12
- TVGN N/A
- Revenue Next Year
- INGN $9.02
- TVGN N/A
- P/E Ratio
- INGN N/A
- TVGN N/A
- Revenue Growth
- INGN 5.15
- TVGN N/A
- 52 Week Low
- INGN $5.70
- TVGN $0.58
- 52 Week High
- INGN $12.91
- TVGN $2.64
- Technical
- Relative Strength Index (RSI)
- INGN 45.81
- TVGN 38.67
- Support Level
- INGN $8.07
- TVGN $0.58
- Resistance Level
- INGN $8.69
- TVGN $0.66
- Average True Range (ATR)
- INGN 0.33
- TVGN 0.04
- MACD
- INGN -0.07
- TVGN -0.00
- Stochastic Oscillator
- INGN 26.45
- TVGN 23.97
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.